Skip to main content
Thorax logoLink to Thorax
. 1982 Jan;37(1):1–10. doi: 10.1136/thx.37.1.1

Alveolitis: the key to the interstitial lung disorders.

B A Keogh, R G Crystal
PMCID: PMC459237  PMID: 7041320

Full text

PDF
5

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barrowcliff D. F., Arblaster P. G. Farmer's lung: a study of an early acute fatal case. Thorax. 1968 Sep;23(5):490–500. doi: 10.1136/thx.23.5.490. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bernardo J., Hunninghake G. W., Gadek J. E., Ferrans V. J., Crystal R. G. Acute hypersensitivity pneumonitis: serial changes in lung lymphocyte subopulations after exposure to antigen. Am Rev Respir Dis. 1979 Nov;120(5):985–994. doi: 10.1164/arrd.1979.120.5.985. [DOI] [PubMed] [Google Scholar]
  3. Bitterman P. B., Crystal R. G. Is there a fibrotic gene? Chest. 1980 Oct;78(4):549–550. doi: 10.1378/chest.78.4.549. [DOI] [PubMed] [Google Scholar]
  4. Carrington C. B., Gaensler E. A., Coutu R. E., FitzGerald M. X., Gupta R. G. Natural history and treated course of usual and desquamative interstitial pneumonia. N Engl J Med. 1978 Apr 13;298(15):801–809. doi: 10.1056/NEJM197804132981501. [DOI] [PubMed] [Google Scholar]
  5. Carrington C. B. Structure and function in sarcoidosis. Ann N Y Acad Sci. 1976;278:265–283. doi: 10.1111/j.1749-6632.1976.tb47038.x. [DOI] [PubMed] [Google Scholar]
  6. Cervantes-Perez P., Toro-Perez A. H., Rodriguez-Jurado P. Pulmonary involvement in rheumatoid arthritis. JAMA. 1980 May 2;243(17):1715–1719. [PubMed] [Google Scholar]
  7. Crystal R. G., Fulmer J. D., Roberts W. C., Moss M. L., Line B. R., Reynolds H. Y. Idiopathic pulmonary fibrosis. Clinical, histologic, radiographic, physiologic, scintigraphic, cytologic, and biochemical aspects. Ann Intern Med. 1976 Dec;85(6):769–788. doi: 10.7326/0003-4819-85-6-769. [DOI] [PubMed] [Google Scholar]
  8. Crystal R. G., Gadek J. E., Ferrans V. J., Fulmer J. D., Line B. R., Hunninghake G. W. Interstitial lung disease: current concepts of pathogenesis, staging and therapy. Am J Med. 1981 Mar;70(3):542–568. doi: 10.1016/0002-9343(81)90577-5. [DOI] [PubMed] [Google Scholar]
  9. Epler G. R., McLoud T. C., Gaensler E. A., Mikus J. P., Carrington C. B. Normal chest roentgenograms in chronic diffuse infiltrative lung disease. N Engl J Med. 1978 Apr 27;298(17):934–939. doi: 10.1056/NEJM197804272981703. [DOI] [PubMed] [Google Scholar]
  10. Gadek J. E., Hunninghake G. W., Zimmerman R. L., Crystal R. G. Regulation of the release of alveolar macrophage-derived neutrophil chemotactic factor. Am Rev Respir Dis. 1980 Apr;121(4):723–733. doi: 10.1164/arrd.1980.121.4.723. [DOI] [PubMed] [Google Scholar]
  11. Gadek J. E., Kelman J. A., Fells G., Weinberger S. E., Horwitz A. L., Reynolds H. Y., Fulmer J. D., Crystal R. G. Collagenase in the lower respiratory tract of patients with idiopathic pulmonary fibrosis. N Engl J Med. 1979 Oct 4;301(14):737–742. doi: 10.1056/NEJM197910043011401. [DOI] [PubMed] [Google Scholar]
  12. Haslam P. L., Cromwell O., Dewar A., Turner-Warwick M. Evidence of increased histamine levels of lung lavage fluids from patients with cryptogenic fibrosing alveolitis. Clin Exp Immunol. 1981 Jun;44(3):587–593. [PMC free article] [PubMed] [Google Scholar]
  13. Haslam P. L., Turton C. W., Heard B., Lukoszek A., Collins J. V., Salsbury A. J., Turner-Warwick M. Bronchoalveolar lavage in pulmonary fibrosis: comparison of cells obtained with lung biopsy and clinical features. Thorax. 1980 Jan;35(1):9–18. doi: 10.1136/thx.35.1.9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Hau T., Ahrenholz D. H., Simmons R. L. Secondary bacterial peritonitis: the biologic basis of treatment. Curr Probl Surg. 1979 Oct;16(10):1–65. doi: 10.1016/s0011-3840(79)80011-8. [DOI] [PubMed] [Google Scholar]
  15. Hinson K. F. Diffuse pulmonary fibrosis. Hum Pathol. 1970 Jun;1(2):275–288. doi: 10.1016/s0046-8177(70)80040-5. [DOI] [PubMed] [Google Scholar]
  16. Hunninghake G. W., Crystal R. G. Mechanisms of hypergammaglobulinemia in pulmonary sarcoidosis. Site of increased antibody production and role of T lymphocytes. J Clin Invest. 1981 Jan;67(1):86–92. doi: 10.1172/JCI110036. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Hunninghake G. W., Crystal R. G. Pulmonary sarcoidosis: a disorder mediated by excess helper T-lymphocyte activity at sites of disease activity. N Engl J Med. 1981 Aug 20;305(8):429–434. doi: 10.1056/NEJM198108203050804. [DOI] [PubMed] [Google Scholar]
  18. Hunninghake G. W., Fulmer J. D., Young R. C., Jr, Gadek J. E., Crystal R. G. Localization of the immune response in sarcoidosis. Am Rev Respir Dis. 1979 Jul;120(1):49–57. doi: 10.1164/arrd.1979.120.1.49. [DOI] [PubMed] [Google Scholar]
  19. Hunninghake G. W., Gadek J. E., Kawanami O., Ferrans V. J., Crystal R. G. Inflammatory and immune processes in the human lung in health and disease: evaluation by bronchoalveolar lavage. Am J Pathol. 1979 Oct;97(1):149–206. [PMC free article] [PubMed] [Google Scholar]
  20. Hunninghake G. W., Gadek J. E., Lawley T. J., Crystal R. G. Mechanisms of neutrophil accumulation in the lungs of patients with idiopathic pulmonary fibrosis. J Clin Invest. 1981 Jul;68(1):259–269. doi: 10.1172/JCI110242. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Hunninghake G. W., Gadek J. E., Young R. C., Jr, Kawanami O., Ferrans V. J., Crystal R. G. Maintenance of granuloma formation in pulmonary sarcoidosis by T lymphocytes within the lung. N Engl J Med. 1980 Mar 13;302(11):594–598. doi: 10.1056/NEJM198003133021102. [DOI] [PubMed] [Google Scholar]
  22. Hunninghake G. W., Kawanami O., Ferrans V. J., Young R. C., Jr, Roberts W. C., Crystal R. G. Characterization of the inflammatory and immune effector cells in the lung parenchyma of patients with interstitial lung disease. Am Rev Respir Dis. 1981 Apr;123(4 Pt 1):407–412. doi: 10.1164/arrd.1981.123.4.407. [DOI] [PubMed] [Google Scholar]
  23. Hunninghake G., Gadek J., Crystal R. Mechanism by which cigarette smoke attracts polymorphonuclear leukocytes to lung. Chest. 1980 Feb;77(2 Suppl):273–273. doi: 10.1378/chest.77.2_supplement.273. [DOI] [PubMed] [Google Scholar]
  24. Janoff A., White R., Carp H., Harel S., Dearing R., Lee D. Lung injury induced by leukocytic proteases. Am J Pathol. 1979 Oct;97(1):111–136. [PMC free article] [PubMed] [Google Scholar]
  25. Judd P. A., Finnegan P., Curran R. C. Pulmonary sarcoidosis: A clinico-pathological study. J Pathol. 1975 Apr;115(4):191–198. doi: 10.1002/path.1711150402. [DOI] [PubMed] [Google Scholar]
  26. Keogh B. A., Crystal R. G. Clinical significance of pulmonary function tests. Pulmonary function testing in interstitial pulmonary disease. What does it tell us? Chest. 1980 Dec;78(6):856–865. doi: 10.1378/chest.78.6.856. [DOI] [PubMed] [Google Scholar]
  27. Lavender J. P., Lowe J., Barker J. R., Burn J. I., Chaudhri M. A. Gallium 67 citrate scanning in neoplastic and inflammatory lesions. Br J Radiol. 1971 May;44(521):361–366. doi: 10.1259/0007-1285-44-521-361. [DOI] [PubMed] [Google Scholar]
  28. Lawrence E. C., Blaese R. M., Martin R. R., Stevens P. M. Immunoglobulin secreting cells in normal human bronchial lavage fluids. J Clin Invest. 1978 Oct;62(4):832–835. doi: 10.1172/JCI109195. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Line B. R., Fulmer J. D., Reynolds H. Y., Roberts W. C., Jones A. E., Harris E. K., Crystal R. G. Gallium-67 citrate scanning in the staging of idiopathic pulmonary fibrosis: Correlation and physiologic and morphologic features and bronchoalveolar lavage. Am Rev Respir Dis. 1978 Aug;118(2):355–365. doi: 10.1164/arrd.1978.118.2.355. [DOI] [PubMed] [Google Scholar]
  30. Line B. R., Hunninghake G. W., Keogh B. A., Jones A. E., Johnston G. S., Crystal R. G. Gallium-67 scanning to stage the alveolitis of sarcoidosis: correlation with clinical studies, pulmonary function studies, and bronchoalveolar lavage. Am Rev Respir Dis. 1981 Apr;123(4 Pt 1):440–446. doi: 10.1164/arrd.1981.123.4.440. [DOI] [PubMed] [Google Scholar]
  31. Martin W. J., 2nd, Gadek J. E., Hunninghake G. W., Crystal R. G. Oxidant injury of lung parenchymal cells. J Clin Invest. 1981 Nov;68(5):1277–1288. doi: 10.1172/JCI110374. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. NIH conference. Pulmonary sarcoidosis: a disease characterized and perpetuated by activated lung T-lymphocytes. Ann Intern Med. 1981 Jan;94(1):73–94. doi: 10.7326/0003-4819-94-1-73. [DOI] [PubMed] [Google Scholar]
  33. Rennard S. I., Hunninghake G. W., Bitterman P. B., Crystal R. G. Production of fibronectin by the human alveolar macrophage: mechanism for the recruitment of fibroblasts to sites of tissue injury in interstitial lung diseases. Proc Natl Acad Sci U S A. 1981 Nov;78(11):7147–7151. doi: 10.1073/pnas.78.11.7147. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Reynolds H. Y., Fulmer J. D., Kazmierowski J. A., Roberts W. C., Frank M. M., Crystal R. G. Analysis of cellular and protein content of broncho-alveolar lavage fluid from patients with idiopathic pulmonary fibrosis and chronic hypersensitivity pneumonitis. J Clin Invest. 1977 Jan;59(1):165–175. doi: 10.1172/JCI108615. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Reynolds H. Y., Newball H. H. Analysis of proteins and respiratory cells obtained from human lungs by bronchial lavage. J Lab Clin Med. 1974 Oct;84(4):559–573. [PubMed] [Google Scholar]
  36. Reynolds H. Y. The importance of lymphocytes in pulmonary health and disease. Lung. 1978;155(3):225–242. doi: 10.1007/BF02730695. [DOI] [PubMed] [Google Scholar]
  37. Rosen Y., Amorosa J. K., Moon S., Cohen J., Lyons H. A. Occurrence of lung granulomas in patients with stage I sarcoidosis. AJR Am J Roentgenol. 1977 Dec;129(6):1083–1085. doi: 10.2214/ajr.129.6.1083. [DOI] [PubMed] [Google Scholar]
  38. Rosen Y., Athanassiades T. J., Moon S., Lyons H. A. Nongranulomatous interstitial pneumonitis in sarcoidosis. Relationship to development of epithelioid granulomas. Chest. 1978 Aug;74(2):122–125. doi: 10.1378/chest.74.2.122. [DOI] [PubMed] [Google Scholar]
  39. Roth C., Huchon G. J., Arnoux A., Stanislas-Leguern G., Marsac J. H., Chretien J. Bronchoalveolar cells in advanced pulmonary sarcoidosis. Am Rev Respir Dis. 1981 Jul;124(1):9–12. doi: 10.1164/arrd.1981.124.1.9. [DOI] [PubMed] [Google Scholar]
  40. Rudd R. M., Haslam P. L., Turner-Warwick M. Cryptogenic fibrosing alveolitis. Relationships of pulmonary physiology and bronchoalveolar lavage to response to treatment and prognosis. Am Rev Respir Dis. 1981 Jul;124(1):1–8. doi: 10.1164/arrd.1981.124.1.1. [DOI] [PubMed] [Google Scholar]
  41. SCADDING J. G. FIBROSING ALVEOLITIS. Br Med J. 1964 Sep 12;2(5410):686–686. doi: 10.1136/bmj.2.5410.686. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Schlueter D. P. Response of the lung to inhaled antigens. Am J Med. 1974 Sep;57(3):476–492. doi: 10.1016/0002-9343(74)90141-7. [DOI] [PubMed] [Google Scholar]
  43. Strumpf I. J., Feld M. K., Cornelius M. J., Keogh B. A., Crystal R. G. Safety of fiberoptic bronchoalveolar lavage in evaluation of interstitial lung disease. Chest. 1981 Sep;80(3):268–271. doi: 10.1378/chest.80.3.268. [DOI] [PubMed] [Google Scholar]
  44. Teilum G. Morphogenesis and development of sarcoid lesions. Similarities to the group of collagenoses. Acta Med Scand Suppl. 1964;425:14–18. doi: 10.1111/j.0954-6820.1964.tb05686.x. [DOI] [PubMed] [Google Scholar]
  45. Turner-Warwick M., Burrows B., Johnson A. Cryptogenic fibrosing alveolitis: clinical features and their influence on survival. Thorax. 1980 Mar;35(3):171–180. doi: 10.1136/thx.35.3.171. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Weinberger S. E., Kelman J. A., Elson N. A., Young R. C., Jr, Reynolds H. Y., Fulmer J. D., Crystal R. G. Bronchoalveolar lavage in interstitial lung disease. Ann Intern Med. 1978 Oct;89(4):459–466. doi: 10.7326/0003-4819-89-4-459. [DOI] [PubMed] [Google Scholar]
  47. Zimmerman P. V., Sinclair R. A. Rapidly progressive fatal silicosis in a young man. Med J Aust. 1977 Nov 19;2(21):704–706. doi: 10.5694/j.1326-5377.1977.tb99228.x. [DOI] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES